Notice of Intent to Sole Source and not a request for quotations for Bruker Spatial Biology GeoMx reagents
ID: 75N96025Q00026Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTE OF HEALTH NIEHSMORRISVILLE, NC, 27560, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Set Aside

8(a) Sole Source (FAR 19.8) (8AN)

Original Source

https://sam.gov/opp/c9ff5f7cf3594f3e9d41841a6306a6e2/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source procurement for Bruker Spatial Biology GeoMx reagents, which will be utilized in spatial transcriptomics experiments at the Molecular Genomics Core lab. This procurement aims to assess gene expression changes in the mouse genome, highlighting the importance of these reagents in advancing genomic research. The acquisition is justified under U.S.C. 1901, allowing for contracts with a single responsible source, with a delivery period scheduled from April 15, 2025, to June 15, 2025. Interested parties may submit capability statements by March 14, 2025, and inquiries can be directed to Christopher Brown at christopher.brown3@nih.gov or by phone at 984-287-3011.

    Point(s) of Contact
    Christopher Brown
    (984) 287-3011
    christopher.brown3@nih.gov
    Files
    Title
    Posted
    3 - Synopsis-Intent to sole source BRUKER SPATIAL 3 10 25.docx
    The National Institute of Environmental Health Sciences (NIEHS) intends to negotiate a sole source procurement with Bruker Spatial Biology for GeoMx reagents, intended for use in spatial transcriptomics experiments in their Molecular Genomics Core lab. This notice, posted on March 10, 2025, emphasizes that it is not a solicitation but rather an intent notice, allowing interested parties to submit capability statements by March 14, 2025. The acquisition is justified under U.S.C. 1901, which permits contracts with only one responsible source. The period for delivery is set from April 15, 2025, to June 15, 2025. Although there is no solicitation package available, inquiries regarding the procurement can be directed to Mr. Christopher Brown at NIEHS. Responses to this notice will only inform the government’s decision on competitive procurement, reiterating the intent to award the contract solely to Bruker Spatial Biology.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source and not a request for quotations for Bruker Spatial Biology GeoMx reagents
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Buyer not available
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    This is a Notice of Intent to Sole Source and not a request for quotations for a SERVICE AGREEMENT FOR MOLECULAR DEVICES FLIPR TETRA
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source service agreement with Molecular Devices LLC for the maintenance of Government-owned Molecular Devices FLIPR-Tetra equipment. This procurement aims to secure factory-trained personnel capable of providing comprehensive mechanical, electrical, and software repair services for a base period of one year, with the option to extend for two additional years. The service is crucial for ensuring the operational integrity and optimal functionality of the equipment utilized by the Calcium Signaling Group at the NIH's National Institute of Environmental Health Sciences (NIEHS) facility in Research Triangle Park, North Carolina. Interested vendors may submit a capability statement by March 14, 2025, and should direct inquiries to Christopher Brown at christopher.brown3@nih.gov or by phone at 984-287-3011.
    Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Sofie Co. for the procurement of Piflufolastat F-18 injection drugs (Pylarify) essential for clinical nuclear medicine procedures at the NIH Clinical Center. The requirement includes 50 patient-ready unit doses of Piflufolastat F-18 and associated fees for unused doses, as these radiopharmaceuticals are critical for diagnosing and treating diseases in patients, adhering to strict FDA and NRC regulations. The contract period is set from March 14, 2025, to March 13, 2026, and interested parties may submit capability statements to Lu Chang at lu-chang.lu@nih.gov by 11:00 AM EST on March 14, 2025, for consideration.
    Fieldline 64 Sensor
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to enter into a sole-source contract with Fieldline Industries, Inc. for the procurement of advanced optically-pumped magnetometers (OPMs) to develop a non-invasive magnetocardiography (MCoG) sensor array. This contract, identified by solicitation number NIMH250014531, aims to enhance the capability to monitor human brain function with high temporal and spatial resolution, addressing current limitations in neuroscience through the delivery of 64 Fieldline V3 sensors and associated electronics, along with research and design services for a compound gradiometer. The procurement is justified as a small business set-aside, as Fieldline is the sole supplier capable of providing these specialized sensors, having successfully collaborated with NIH for over five years. Interested parties should submit their responses electronically to Joseph Kennedy at joseph.kennedy@nih.gov by the specified deadline, with the contract period commencing on April 1, 2025.
    Acquisition of a Service Contract for Thermo Lumos Mass Spectrometer
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a non-competitive service contract for the maintenance of a Thermo Lumos Mass Spectrometer. This procurement, classified under NAICS code 811210, aims to ensure uninterrupted analytical support for the National Institute of Digestive, Diabetes & Kidney Diseases (NIDDK) research, as the complexity of the spectrometer requires specialized technicians from Thermo Electron North America LLC. The contract will be effective for three years and includes key tasks such as emergency technical support and scheduled preventive maintenance. Interested parties may respond with their capabilities by the deadline of March 24, 2024, although this announcement is not a request for competitive proposals. For further inquiries, contact Amber Harris at amber.harris@nih.gov.
    Maintenance and Repair Service for Illumina Laboratory Equipment NovaSeq 6000 Sequencer
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to provide maintenance and repair services for the Illumina NovaSeq 6000 Sequencer, a critical piece of laboratory equipment used in genetic and genomic research. The contractor will be responsible for comprehensive services, including parts, labor, travel, remote technical support, on-site assistance, software and hardware updates, and application support, all performed by certified Illumina technicians. This initiative is vital for ensuring the operational integrity of the NIH's research capabilities, with the performance period set from April 13, 2025, to October 12, 2025. Interested parties should contact Emily Palombo at emily.palombo@nih.gov for further details regarding the procurement process.
    Notice of Intent to Sole Source
    Buyer not available
    The Department of Defense, through the Army Medical Research Acquisition Activity, intends to negotiate a sole source contract with Metabolon, Inc. for metabolomics analysis services over a five-year period, valued at approximately $3.96 million. The contract will support the U.S. Army Research Institute of Environmental Medicine by providing essential analyses of biological samples, including urine and blood, which are critical for ongoing and planned research studies. Metabolon is uniquely qualified to fulfill this requirement due to its extensive library of over 4,000 metabolites and advanced analytical capabilities, including ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). Interested firms may express their capability by March 13, 2025, and should contact Kasey Carroll at kasey.l.carroll.civ@health.mil or Jennifer Bassett at jennifer.s.bassett.civ@health.mil for further information.
    In-VitroCell NU-5710 Direct Heat CO2 Incubator
    Buyer not available
    Combined Synopsis/Solicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking to procure an In-VitroCell NU-5710 Direct Heat CO2 Incubator. This item is typically used for laboratory research and is intended to replace the current incubators being utilized at NIEHS. The procurement is being conducted on a sole source basis with Nuaire, Inc. The delivery date for this purchase is September 30, 2024. Interested parties may submit a capability statement by July 25, 2024, 5:00 PM EST. For more information, please contact Brian Moyer at moyerbd@niehs.nih.gov.
    6550--GenMark ePlex Reagents - Notice of Intent to Sole Source
    Buyer not available
    The Department of Veterans Affairs (VA) intends to negotiate a sole source contract for GenMark ePlex Reagents, specifically the ePlex Respiratory Pathogen Panel 2, to support testing for respiratory viruses, including COVID-19, at the Chillicothe VA Medical Center in Ohio. This procurement is justified under FAR Part 6.302-1, which allows for contracts with a single responsible source when only one vendor, Roche Diagnostics Corp., is deemed capable of fulfilling the specific requirements due to the unique compatibility of the reagents with the existing GenMark ePlex Analyzer. The anticipated contract will be a firm fixed price with no option years, and responses to this notice must be submitted by 4:00 pm EST on March 13, 2025, to Contract Specialist Lonnelle Jones at lonnelle.jones@va.gov.
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Notice of Intent to Sole Source for procurement from Cardinal Health, Inc. This opportunity involves the acquisition of surgical and medical instruments, which are critical for various healthcare applications within the NIH. The goods are essential for maintaining the operational capabilities of medical facilities, ensuring that healthcare providers have access to the necessary tools for patient care. Interested parties can reach out to Kristin Nagashima at kristin.nagashima@nih.gov for further inquiries regarding this procurement.